Method for the detection of risk factors associated with myocardial infarction
a risk factor and myocardial infarction technology, applied in the field of myocardial infarction, can solve the problems and achieve the effect of increasing the risk of myocardial infarction
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Image
Examples
example 1
[0094] Subjects, Materials and Methods
[0095] Subjects:
[0096] Blood samples were collected from 500 consecutive myocardial infarction patients and 500 normal controls of the genetically isolated Newfoundland population. The population consists mainly of descendants of English and Irish settlers who arrived in the 18th and 19th centuries. The geographic and social isolation of the island has ensured very little inward migration for several hundred years, and thus has lead to a small population (530,000 individuals) with a relatively homogenous genetic background, ideal for the study of complex multifactorial diseases such as myocardial infarction.
[0097] Patients categorized in the myocardial infarction group represented those presenting to the emergency department or within one of the Health Care Corporation of St. John's hospitals with symptoms and biochemical evidence suggestive of myocardial infarction. Only patients with cardiac Troponin I values greater than 2.0 μg / L (Axsym, A...
example 2
[0120] Subjects, Materials and Methods
[0121] Blood samples were collected from 230 additional patients with MI and 79 additional normal controls, using the methods and m,aterials set out in Example 1. The cumulative summary of the results based total 730 patients with MI and 579 normal controls are given in the following tables and figures:
[0122] Results
[0123] Genotyping FIIG20210A, FVL and FXIII-A V34L
[0124] The genotype distributions, carrier frequencies, and allele frequencies of FII 20210A, FVL, and FXIII-A L34 in both the MI patient and the control populations are given in Table 3: distributions of genotypes, and carrier and allele frequencies of FIIG20210A, FVL and FXIII-A V34L in MI patient and normal control populations. (MI: myocardial infarction, NC: normal control, OR: odds ratio).
GenotypeMI (n = 730)NC (n = 579)OR (95% CI)P valueFIIG20210AG / G710 (97.3%)572 (98.8%)G / A 20 (2.7%) 7 (1.2%)A / A 0 (0%) 0 (0%)Carrier F. 2.7% 1.2%2.302 (0.967, 5.482)0.053Allele F. 1.4% 0.6%...
PUM
Property | Measurement | Unit |
---|---|---|
Fraction | aaaaa | aaaaa |
Fraction | aaaaa | aaaaa |
Fraction | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com